The rejuvenation of testosterone: philosopher’s stone or Brown-Séquard Elixir?

Basaria, S. , Coviello, A.D. , Travison, T.G. , Storer, T.W. , Farwell, W.R. , Jette, A.M. et al. (2010) Adverse events associated with testosterone administration. N Eng J Med 10.1056/NEJMoa1000485.

Bhasin, S. ( 2010) The brave new world of function-promoting anabolic therapies: testosterone and frailty. J Clin Endo Metab 95: 509-511.

Bhasin, S. , Cunningham, G.R. , Hayes, F.J. , Matsumoto, A.M. , Snyder, P.J. , Swerdloff, R.S. et al. (2010) Testosterone therapy in adult men with androgen deficiency syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endo Metab 95: 2536-2559.

Brown-Séquard, C.E. ( 1889) The effects produced on man by subcutaneous injection of a liquid obtained from the testicles of animals. Lancet 137: 105-107.

Channer, K.S. and Jones, T.H. ( 2003) Cardiovascular effects of testosterone: implications of the ‘male menopause’? Heart 89: 121-122.

Harman, S.M. , Metter, E.J. , Tobin, J. , Pearson, J. and Blackmann, M.R. ( 2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endo Metab 86: 724-731.

Matfin, G. ( 2009) Disorders of the male genitourinary system, In: Porth, C.M. and Matfin, G. (eds). Pathophysiology: Concepts of Altered Health States , 8th edn, Wolters Kluwer Health : Philadelphia, PA.

Raivio, T. , Falardeau, J. , Dwyer, A. , Quinton, R. , Hayes, F.J. , Hughes, V.A. et al. (2007) Reversal of idiopathic hypogonadotropic hypogonadism . N Eng J Med 357: 863-873.

Wang, C. , Nieschlag, E. , Swerdloff, R. , Behre, H.M. , Gooren, L.J. , Kaufman, J.M. et al. (2008) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM and EAU recommendations. E J Endo 150: 507-514.

Wu, F.C.W. , Tajar, A. , Beynon, J.M. , Pye, S.R. , Silman, A.J. , Finn, J.D. et al. (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. N Eng J Med 10.1056/NEJMoa0911101.